REVIVA PHARMA HLDGS INC
RVPHReviva Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. Founded to leverage its expertise in drug discovery and development, Reviva aims to address unmet medical needs through innovative solutions. The company's pipeline includes candidates targeting conditions such as depression, anxiety, and other neuropsychiatric disorders.
Company News
Reviva Pharmaceuticals (NASDAQ: RVPH) closed a $10 million public offering on March 20, 2026, selling 6.67 million shares at $1.50 per share along with Series G and H warrants. The company plans to use proceeds for R&D activities, including the RECOVER-2 Phase 3 trial for brilaroxazine in schizophrenia treatment. Post-offering, Reviva has approxi...
Reviva Pharmaceuticals (NASDAQ: RVPH) announced the pricing of a $10 million public offering, selling 6.67 million shares at $1.50 per share along with Series G and H warrants. The company plans to use net proceeds to fund its RECOVER-2 Phase 3 trial for brilaroxazine in schizophrenia and general corporate purposes. The offering is expected to cl...
Reviva Pharmaceuticals announced a public offering of 6.67 million shares at $1.50 per share with accompanying warrants, raising approximately $10 million in gross proceeds. The company plans to use the funds to support research and development activities, including its RECOVER-2 Phase 3 trial for brilaroxazine in schizophrenia treatment, along w...
Reviva Pharmaceuticals Holdings, Inc. announced that its Founder, President, and CEO Laxminarayan Bhat will present at the Sachs 9th Annual Neuroscience Innovation Forum on January 11, 2026, in San Francisco. The late-stage biopharmaceutical company is developing therapies for CNS, inflammatory, and cardiometabolic diseases, with two main drug ca...
Reviva Pharmaceuticals will present research data on brilaroxazine's treatment effects on negative symptoms in schizophrenia patients at the CNS Summit 2025 in Boston, Massachusetts.
